Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07376733 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Controlled Breathing on Cardiorespiratory Variables in Multiple Myeloma

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jun 2026 → Dec 2026
See other at-risk trials from Universidad Complutense de Madrid

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 8 more changesShow less
    • Primary completion pushed from Jun 2026 to Dec 2026
    • Study completion pushed from Sep 2026 to Feb 2027
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 2026 to Feb 11, 2026
    • Eligibility criteria expanded, about 22 words
    • Secondary endpoints: details revised at 7 of 7 entries
    • Publications: details revised at 7 of 7 entries
    • Study description expanded, about 2 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A randomized, parallel, double-blind, controlled, clinical trial. Two groups of participants will be included, both receiving a therapeutic exercise intervention and an educational session on the importance of proper breathing over a 6-week period. One of the groups will additionally perform a home-based controlled breathing exercise protocol. Pre- and post-intervention assessments (6 weeks) will be conducted, along with a follow-up evaluation 4 weeks after completion of the intervention. The goal is to determine the effectiveness of adding a controlled breathing exercise program to a therapeutic exercise intervention on cardiorespiratory variables in individuals with multiple myeloma.
Trial Details
NCT Number NCT07376733
Lead Sponsor Universidad Complutense de Madrid
Conditions
(from sponsor)		 Multiple Myeloma (MM), Breathing Techniques, Breathing Exercises, Exercise Activity, Diaphragmatic Breathing, Heart Rate Variability (HRV)
Related terms Hypoventilation, Multiple Myeloma, Respiratory Aspiration
Enrollment 26 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov